Exicure is an Illinois-based biotechnology company that researches and develops nucleic acid therapeutics for the treatment of neurological diseases and genetic disorders.
Business Model:
Revenue: $5.7M
Employees: 11-50
Address: 2430 N. Halsted Street
City: Chicago
State: IL
Zip: 60614
Country: US
Exicure is an Illinois-based biotechnology company that researches and develops nucleic acid therapeutics for the treatment of neurological diseases and genetic disorders.
Contact Phone:
+18476731700
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
12/19/2019
Ticker Symbol:
XCUR
IPO Price:
$2.75/share
Amount Raised:
$28M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|